Aigen Investment Management LP Grows Position in Chemed Co. (NYSE:CHE)

Aigen Investment Management LP lifted its holdings in shares of Chemed Co. (NYSE:CHE) by 300.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,002 shares of the company’s stock after buying an additional 1,502 shares during the period. Aigen Investment Management LP’s holdings in Chemed were worth $1,061,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. M&T Bank Corp boosted its position in Chemed by 14.4% in the fourth quarter. M&T Bank Corp now owns 964 shares of the company’s stock worth $511,000 after purchasing an additional 121 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Chemed by 10.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company’s stock worth $72,149,000 after purchasing an additional 13,394 shares during the last quarter. SRS Capital Advisors Inc. boosted its position in Chemed by 39.2% in the fourth quarter. SRS Capital Advisors Inc. now owns 135 shares of the company’s stock worth $72,000 after purchasing an additional 38 shares during the last quarter. US Bancorp DE boosted its position in Chemed by 1.9% in the fourth quarter. US Bancorp DE now owns 4,129 shares of the company’s stock worth $2,187,000 after purchasing an additional 77 shares during the last quarter. Finally, Maripau Wealth Management LLC purchased a new position in Chemed in the fourth quarter worth about $358,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, February 27th.

Insider Transactions at Chemed

In other Chemed news, VP Brian C. Judkins bought 145 shares of the firm’s stock in a transaction that occurred on Monday, December 30th. The shares were bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Up 1.3 %

NYSE CHE opened at $595.07 on Thursday. The stock’s 50-day moving average price is $549.47 and its 200-day moving average price is $563.54. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62. The company has a market capitalization of $8.96 billion, a P/E ratio of 30.07, a price-to-earnings-growth ratio of 2.15 and a beta of 0.48.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date of this dividend is Monday, February 24th. Chemed’s dividend payout ratio (DPR) is currently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.